1. Lane TA. Leukocyte reduction of cellular blood components. Effectiveness, benefits, quality control, and costs. Arch Pathol Lab Med. 1994. 118:392–404.
2. Miller JP, Mintz PD. The use of leukocyte-reduced blood components. Hematol Oncol Clin North Am. 1995. 9:69–90.
Article
3. Dzik S, Aubuchon J, Jeffries L, Kleinman S, Manno C, Murphy MF, et al. Leukocyte reduction of blood components: public policy and new technology. Transfus Med Rev. 2000. 14:34–52.
Article
4. Ratko TA, Cummings JP, Oberman HA, Crookston KP, DeChristopher PJ, Eastlund DT, et al. Evidence-based recommendations for the use of WBC-reduced cellular blood components. Transfusion. 2001. 41:1310–1319.
Article
5. Da Ponte A, Bidoli E, Talamini R, Steffan A, Abbruzzese L, Toffola RT, et al. Pre-storage leucocyte depletion and transfusion reaction rates in cancer patients. Transfus Med. 2005. 15:37–43.
Article
6. Hammer JH, Mynster T, Reimert CM, Pedersen AN, Nielsen HJ. Reduction of bioactive substances in stored donor blood: prestorage versus bedside leucofiltration. Eur J Haematol. 1999. 63:29–34.
Article
7. Sweeney JD. Universal leukoreduction of cellular blood components in 2001? Yes. Am J Clin Pathol. 2001. 115:666–673.
Article
8. Heddle NM, Klama L, Meyer R, Walker I, Boshkov L, Roberts R, et al. A randomized controlled trial comparing plasma removal with white cell reduction to prevent reactions to platelets. Transfusion. 1999. 39:231–238.
Article
9. Ledent E, Berlin G. Inadequate white cell reduction by bedside filtration of red cell concentrates. Transfusion. 1994. 34:765–768.
Article
10. Popovsky MA. Quality of blood components filtered before storage and at the beside: implications for transfusion practice. Transfusion. 1996. 36:470–474.
Article
11. Bassuni WY, Blajchman MA, Al-Moshary MA. Why implement universal leukoreduction? Hematol Oncol Stem Cell Ther. 2008. 1:106–123.
Article
12. Report of the US Department of Health and Human Services. The 2009 national blood collection and utilization survey report. 2011. Washington, DC: US Department of Health and Human Services, Office of the Assistant Secretary for Health.
13. Kim S. Development of national blood collection and utilization data monitoring system. 2010. Seoul: National Institute of Health, Korea.